Granules India share news, announcements and annual reports
NSE: GRANULESBSE: 532482Pharmaceuticals & BiotechnologySmall Cap
Granules India Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2002 on BSE, Jun 2005 on NSE
Last close ₹820.70down ₹19.05 (2.27%)BSE ₹819.55
Share price at the NSE close on 2 Nov 2026. Previous close ₹839.75.
2 Nov: open ₹838.50, high ₹849.15, low ₹808.30
52-week range of traded prices to 2 Nov 2026
₹529.85Low, 25 Nov 2025₹923.65High, 15 Sep 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22,387 Cr403rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.80
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.21%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 9,81,683
Granules India share news and announcements
1,066 announcements, routine notices left out, newest first. Page 17 of 22.
May 2014
Apr 2014
Feb 2014
20 Feb · Board meeting
15 Feb · Updates
Company has paid consideration to the Shareholders of the Auctus Pharma Limited in relation to the acquisition of Auctus Pharma Limited.
Jan 2014
16 Jan · Board meeting
Inter-alia to consider and approve the Un -Audited Financial Results for the Third quarter ended December 31, 2013. Further the Company has informed the Exchange that as per the SEBI (Prohibition of Insider Trading) Regulations, 1992 and Granules India Limited - Code of Conduct for Prevention of Insider Trading, the trading window of M/s Granules India Limited remains closed from December 31, 2013 to January 29, 2014 (both days inclusive) in view of the Board meeting scheduled as aforesaid.
Dec 2013
31 Dec · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated December 31, 2013 has allotted 24,000 equity shares in consequent to exercise of options under ESOP 2009.
Nov 2013
Oct 2013
30 Oct · Results
21 Oct · Board meeting
Inter-alia to consider and approve the Un-audited Financial Results of the Company for the Second quarter ended September 30, 2013.17 Oct · Business
Share Transfer and shareholders/Investors Grievance Committee at their meeting dated October 16, 2013 have approved to allot 5,000 equity shares in consequent to excercise of options under ESOP 2009.
Sep 2013
2 Sep · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 31, 2013 have approved to allot 13000 equity shares in consequent to exercise of options under ESOP 2009.
Aug 2013
21 Aug · Disclosure of Voting Pattern - Clause 35A
13 Aug · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 13, 2013 have approved to allot 9,000 equity shares in consequent to exercise of options under ESOP 2009.2 Aug · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 02, 2013 have approved to allot 11,000 equity shares in consequent to exercise of options under ESOP 2009.
Jul 2013
17 Jul · Board meeting
Inter-alia to consider and approve the Un-Audited Financial Results for the first quarter ended June 30, 2013.11 Jul · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated July 11, 2013 have approved to allot 72,000 equity shares in consequent to exercise of options under ESOP 2002 & ESOP 2009.
Jun 2013
12 Jun · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated June 12, 2013 has approved to allot 16,000 equity shares in consequent to exercise of options under ESOP 2009.